Announcements Trials
Browse Landscape

Status

Unknown 4Completed 4Not yet recruiting 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 22Observational 4

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Neoplasms 1Feasibility 1

Interventions

Blood Specimen Collection 85Surveys and Questionnaires 83Surgical Procedures, Operative 44Drug Therapy 32Radiotherapy 27Biopsy 26Amplified Fragment Length Polymorphism Analysis 24Neoadjuvant Therapy 23Immunohistochemistry 22Gene Expression Profiling 21Bevacizumab 19Data Collection 18Immunotherapy 17Ultrasonography 16Positron Emission Tomography Computed Tomography 16Magnetic Resonance Spectroscopy 16Liquid Biopsy 16pembrolizumab 15Nivolumab 15Watchful Waiting 14Radiosurgery 14Observation 14Microarray Analysis 14Magnetic Resonance Imaging 14Interviews as Topic 14Immune Checkpoint Inhibitors 13Colonoscopy 13Capecitabine 13Polymerase Chain Reaction 12Paclitaxel 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Observational × pertuzumab × Clear all
NCT05912062 2023-09-29

BiOnHER

Institut Català d'Oncologia

Unknown
80 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT05177666 2022-01-04

a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors

The University of Hong Kong-Shenzhen Hospital

Unknown
120 enrolled

Feasibility

NCT01850628 2021-10-05

NSABP Biospecimen Discovery Project

NSABP Foundation Inc

Unknown
50 enrolled
Breast

Breast Neoplasms

NCT04683445 2020-12-24

Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown
80 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡